Hacker News Reader

> The price for EpiPens went up because no one else was able to make a competing product that didn't malfunction or deliver the wrong dose of epinephrine.

Price hasn't gone up as much in the UK where a state monopoly negotiates.

View on HN

And none of this stuff is being invented in the UK either. US is the king of drug discovery. I'm not saying that I like the current system, because in many ways I don't, but let's not ignore the fact that countries like the UK are not producers.

Reply on news.ycombinator.com